The mainstay of management of VWD is<unk><unk> .<unk><unk>  of<unk><unk> 's<unk>  ( vWD) involves normalizing the<unk><unk>  factor and factor VIII levels. Endogenous factor levels can be increased by the use of desmopressin or by infusing exogenous coagulation factors example high-purity or low-purity<unk><unk>  factor concentrate.<unk><unk>  depends on the type of<unk><unk> 's<unk> . Desmopressin is used for type 1 and 2<unk><unk> 's<unk> .<unk><unk>  factor-factor VIII or<unk><unk>  factor concentrate is used in some of type 2<unk><unk> 's<unk>  and all of type 3<unk><unk> 's<unk> . Alternate  or additional<unk>  involves the use of tranexamic acid or aminocaproic acid.
Von Willebrand disease medical therapy
Antithrombin III deficiency medical therapy
Glanzmann's thrombasthenia medical therapy
Antiphospholipid syndrome medical therapy
Disseminated intravascular coagulation medical therapy
Essential thrombocytosis medical therapy
Thrombophilia medical therapy
Heparin-induced thrombocytopenia medical therapy